Schoen Eric's Form 4 filing
Filana Therapeutics, Inc. (FLNA) · filed Dec 3, 2024
- Accession no.
- 0001437749-24-036546
- Filed
- Dec 3, 2024
- Trade date
- Nov 29, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $238.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schoen EricCIK 0001532303 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2024 | Common Stock | MOption exerciseAcquired | +50,000 | $1.18 | +$59,000 | 71,300 | Direct | |
| Nov 29, 2024 | Common Stock | SSaleDisposed | −2,000 | $3.82 | −$7,640 | 0 | Indirect | |
| Nov 29, 2024 | Common Stock | SSaleDisposed | −59,800 | $3.86 | −$230,828 | 11,500 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2024 | Common Stock | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.